708 results on '"Mehta, Rohtesh S."'
Search Results
2. Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis
3. Umbilical Cord Blood Transplantation
4. Graft-Versus-Host Disease
5. List of Contributors
6. Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma
7. A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement
8. Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes
9. Interplay between donor age and HLA-DP matching in 10/10 HLA-matched unrelated donor HCT
10. SOHO State of the Art Updates and Next Questions | Current Status and Future Directions of Donor Selection
11. Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities
12. Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial
13. Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial
14. HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection
15. Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
16. Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations
17. Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial
18. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation
19. Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit
20. Mycophenolate mofetil is associated with inferior overall survival in cytomegalovirus seropositive patients with acute myeloid leukemia undergoing hematopoietic cell transplantation
21. Self-Reported Late Effects and Quality of Life (QOL) of Long-Term Survivors of Severe Aplastic Anemia Who Have Undergone Allogeneic Hematopoietic Cell Transplant (HCT)
22. Effector Site Immune Dynamics in Refractory Chronic Graft-Versus-Host Disease: A Rockstar Trial Companion Study after Belumosudil Treatment.
23. Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality
24. Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors
25. Ex Vivo Mesenchymal Precursor Cell–Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery
26. Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHD
27. Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients
28. Post‐transplantation cyclophosphamide versus conventional graft‐versus‐host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation
29. Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age
30. Endophthalmitis, Cutaneous Nodules, and Brain Lesions in Stem Cell Transplant Recipient
31. Pick Your Poison: Higher Risk of Relapse (older MSD) or A Higher Risk of Non-Relapse Mortality (younger MUD)?
32. Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
33. A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
34. Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials
35. Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia
36. Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation
37. Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant
38. Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age.
39. EXABS-127-CT Donor Selection in 2023: What is New?
40. P1270: MYELOABLATIVE FRACTIONATED BUSULFAN-BASED CONDITIONING REGIMEN IN PATIENTS WITH AML AND MDS: RESULTS OF A RANDOMIZED CLINICAL TRIAL COMPARING 2 FRACTIONATION SCHEDULES
41. Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?
42. Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
43. Cord Blood Transplants Versus Other Sources of Allografts: Comparison of Data in Adult Setting
44. Ex Vivo Cord Blood Manipulation: Methods, Data, and Challenges
45. Correction to: Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation
46. 33 - Graft-Versus-Host Disease
47. 8 - Umbilical Cord Blood Transplantation
48. Impact of Type of Induction Therapy on Outcomes in Older Adults with AML after Allogeneic Stem Cell Transplantation
49. Ex Vivo Mesenchymal Precursor Cell–Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery
50. Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.